Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015

Details for Mechanism ID: 10263
Country/Region: Nigeria
Year: 2010
Main Partner: American Society for Microbiology
Main Partner Program: NA
Organizational Type: Unknown
Funding Agency: HHS/CDC
Total Funding: $450,000

ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAY

This is a continuing activity with funding initiated in late COP07. ASM has the capacity to support the

PEPFAR program by ensuring that laboratories possess the necessary organizational and technical

infrastructure to provide quality laboratory testing and results in support of HIV prevention, care, and

treatment programs, especially for tuberculosis (TB) and opportunistic infections (OI). ASM can provide

technical assistance through carefully chosen experts from among ASM's more than 5,000 clinical

laboratory microbiologists and immunologists worldwide. Plans are to continue to strengthen a strong

cadre of local Nigerian microbiologists in order to ensure sustainability and an ongoing, standardized

transfer of skills. ASM has also within its staff a monitoring and evaluation (M&E) expert, who assists

ASM, as well as, local Nigerian M&E and technical experts with identifying microbiology-specific quality

and technical indicators to introduce in the national M&E system.

Funding for Laboratory Infrastructure (HLAB): $450,000

ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAY - ASM will continue to focus on improving the quality and capacity of TB and OI diagnosis in Nigeria. The following activities will support this goal: 1) improvement of training for simple OI diagnosis (microscopy); 2) development of a comprehensive, integrated quality management system for basic microbiology, 3) review and improvements to the basic microbiology curriculum (and SOP's) currently used in Nigeria, 3) assisting via onsite mentoring and guidance with providing technical support for development of a proficiency program for OIs to assist with accreditation processes; 4) offering technical assistance for QMS implementation for TB culture moving towards accreditation. ASM will continue to work closely with PEPFAR-Nigeria Lab Technical Working Group (LTWG) to ensure that these activities are coordinated with the (Government of Nigeria) GON and those organizations currently supporting TB and OI diagnosis and treatment in Nigeria (including, UMD- ACTION, Harvard-APIN, German Leprosy Group, GHAIN, Netherlands Leprosy Group, Damien Foundation of Belgium (DFB) and WHO. ASM will work through the LTWG to ensure that activities and deliverables are developed and implemented in a harmonized fashion.

EMPHASIS AREAS: The major emphasis of this activity is local organizational and human capacity development in quality assurance and quality improvement of laboratory testing.

POPULATIONS BEING TARGETED: ASM will develop/improve training programs provided to laboratorians working in clinical health care facilities for improved diagnosis of TB and OIs. ASM will also improve the infrastructure of laboratories where these individuals currently work.

REACHING THE VISION: This activity will enable ASM to reach its vision and long-term strategy of building resource-limited countries' ability to better diagnose infectious diseases through quality-assured laboratory procedures. The main emphasis is in transferring knowledge to Nigerian laboratorians thus human capacity development via training and mentoring in order to ensure that the activity is sustained over the years. ASM's activities also contribute to narrowing the gender gap in Nigeria by offering knowledge transfer opportunities to both female and male Nigerian laboratorians.

LINKS TO OTHER USG RESOURCES/DONOR SUPPORT: While there is no direct link to other USG resources and donor support, ASM places great emphasis on gathering information on what other donors are doing, in order to prevent duplicating efforts and act more in a leveraging capacity.

Cross Cutting Budget Categories and Known Amounts Total: $450,000
Human Resources for Health $450,000
Key Issues Identified in Mechanism
Tuberculosis